These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7670396

  • 1. Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remission.
    Ferrant A, Doyen C, Delannoy A, Straetmans N, Martiat P, Mineur P, Bosly A, Van den Berghe H, Michaux JL.
    Bone Marrow Transplant; 1995 May; 15(5):685-90. PubMed ID: 7670396
    [Abstract] [Full Text] [Related]

  • 2. The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogeneic bone marrow transplantation.
    Schouten HC, van Putten WL, Hagemeijer A, Blijham GH, Sonneveld P, Willemze R, Slater R, van de Lely J, Verdonck LF, Löwenberg B.
    Bone Marrow Transplant; 1991 Nov; 8(5):377-81. PubMed ID: 1768973
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission.
    Ferrant A, Doyen C, Delannoy A, Cornu G, Martiat P, Latinne D, De Bruyère M, Bosly A, Michaux JL, Sokal G.
    Bone Marrow Transplant; 1991 Apr; 7(4):303-9. PubMed ID: 2070137
    [Abstract] [Full Text] [Related]

  • 4. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
    Jourdan E, Maraninchi D, Reiffers J, Gluckman E, Rio B, Jouet JP, Michallet M, Molina L, Archimbaud E, Harousseau JL, Ifrah N, Attal M, Guilhot F, Kuentz M, Guyotat D, Pico JL, Dauriac C, Legros M, Dreyfus F, Bordigoni P, Leblond V, Gratecos N, Varet B, Auzanneau C, Blaise D.
    Bone Marrow Transplant; 1997 May; 19(9):875-81. PubMed ID: 9156260
    [Abstract] [Full Text] [Related]

  • 5. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E.
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [Abstract] [Full Text] [Related]

  • 6. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome.
    Tomás F, Gómez-García de Soria V, López-Lorenzo JL, Arranz R, Figuera A, Cámara R, Alegre A, Fernández-Rañada JM.
    Bone Marrow Transplant; 1996 Jun; 17(6):979-84. PubMed ID: 8807103
    [Abstract] [Full Text] [Related]

  • 7. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC, Labopin M, Frassoni F, Milpied N, Attal M, Blaise D, Meloni G, Iori AP, Michallet M, Willemze R, Deconninck E, Harousseau JL, Polge E, Rocha V.
    J Clin Oncol; 2008 Jul 01; 26(19):3183-8. PubMed ID: 18506024
    [Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission.
    Vey N, Blaise D, Stoppa AM, Bouabdallah R, Lafage M, Sainty D, Cowen D, Viens P, Lepeu G, Blanc AP.
    Bone Marrow Transplant; 1994 Sep 01; 14(3):383-8. PubMed ID: 7994259
    [Abstract] [Full Text] [Related]

  • 9. Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ferrant A, Labopin M, Frassoni F, Prentice HG, Cahn JY, Blaise D, Reiffers J, Visani G, Sanz MA, Boogaerts MA, Löwenberg B, Gorin NC.
    Blood; 1997 Oct 15; 90(8):2931-8. PubMed ID: 9376573
    [Abstract] [Full Text] [Related]

  • 10. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS, Lie AK, Liang R, Au WY, Kwong YL.
    Bone Marrow Transplant; 2007 Aug 15; 40(4):339-47. PubMed ID: 17572712
    [Abstract] [Full Text] [Related]

  • 11. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH, Beelen DW, Kroll M, Trzensky S, Stein C, Schaefer UW.
    Bone Marrow Transplant; 1998 Jan 15; 21(2):159-66. PubMed ID: 9489633
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.
    Blaise D, Attal M, Reiffers J, Michallet M, Bellanger C, Pico JL, Stoppa AM, Payen C, Marit G, Bouabdallah R, Sotto JJ, Rossi JF, Brandely M, Hercend T, Maraninchi D.
    Eur Cytokine Netw; 2000 Mar 15; 11(1):91-8. PubMed ID: 10705305
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
    Keating S, Suciu S, de Witte T, Mandelli F, Willemze R, Resegotti L, Broccia G, Thaler J, Labar B, Damasio E, Bizzi B, Rotoli B, Vekhoff A, Muus P, Petti MC, Dardenne M, Solbu G, Vegna ML, Zittoun RA.
    Bone Marrow Transplant; 1996 Jun 15; 17(6):993-1001. PubMed ID: 8807105
    [Abstract] [Full Text] [Related]

  • 16. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group].
    Hübner G, Link H, Schönrock-Nabulsi P, Wandt H, Gramatzki M, Löffler B, Fackler-Schwalbe I, Queisser W, Brack N, Geer T, Raab M, Ohl S, Schneider B, Schneider C, Freund M, Poliwoda H, Ehninger G.
    Med Klin (Munich); 1996 Apr 12; 91 Suppl 3():26-32. PubMed ID: 8692115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative cost of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission.
    Dufoir T, Saux MC, Terraza B, Marit G, Guessard S, Foulon G, Reiffers J.
    Bone Marrow Transplant; 1992 Oct 12; 10(4):323-9. PubMed ID: 1422487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK, Castellino SM, Lehmann LE, Eickhoff CE, Tarbell NJ, Sallan SE, Weinstein HJ, Billett AL.
    Bone Marrow Transplant; 1996 May 12; 17(5):763-8. PubMed ID: 8733695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.